{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:35:15Z","timestamp":1785796515409,"version":"3.56.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Biological evidence has revealed antitumor effect of vitamin D, but whether it could predict the response to neoadjuvant chemotherapy (NAC) in breast cancer (BC) patients remains inconclusive. The aim was to investigate the association between pretreatment vitamin D level and response to NAC and subsequent survival outcomes in BC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>The authors systematically searched the Medline, Embase, Cochrane Library, and Web of Science databases and clinical trial registries to identify relevant articles from inception to 8 October 2024. Eligible studies investigating the associations between pretreatment plasma vitamin D and response to NAC in BC patients were selected according to the predefined criteria, with the study characteristics extracted by two reviewers. The primary outcome was pathological complete response (pCR), while overall pathological response and event-free survival (EFS) were adopted as secondary outcomes. Summary effect estimates of odds ratios (ORs) or hazard ratios (HRs) with 95% CIs were pooled using a random-effects model. Subgroup and sensitivity analyses were performed based on study characteristics and methodological quality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six retrospective cohort studies involving 1291 BC patients were included. The authors observed a significant association between pretreatment vitamin D deficiency and 50% increased odds of non-pCR after NAC (OR=1.50, 95% CI: 1.11\u20132.03, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.008) with no heterogeneity (<jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>=0%). The authors also identified a significant association of vitamin D with the overall pathological response (OR=1.33, 95% CI: 1.01\u20131.75, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.046). A similar association with EFS (HR=1.27, 95% CI: 0.92\u20131.75, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.139) was also noted although the effect estimate was not statistically significant. Sensitivity analyses based on methodological quality showed consistent findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Pretreatment vitamin D deficiency is associated with an inferior response to NAC in BC patients. Our meta-analysis advocates further prospective studies with large sample sizes before vitamin D supplementation could be administered to improve NAC response and subsequent prognosis of BC patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000002142","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:01:43Z","timestamp":1731931303000},"page":"8126-8135","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Pretreatment plasma vitamin D and response to neoadjuvant chemotherapy in breast cancer: evidence from pooled analysis of cohort studies"],"prefix":"10.1097","volume":"110","author":[{"given":"Chi","family":"Shu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Division of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Department of Oncology and Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Colorectal Cancer Center, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-0143","authenticated-orcid":false,"given":"Yazhou","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology and Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"R1-20250824","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250824","first-page":"CD005002","article-title":"Preoperative chemotherapy for women with operable breast cancer","volume":"2","author":"van der Hage","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2147\/DDDT.S253961","article-title":"Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","article-title":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges","volume":"31","author":"Heil","year":"2020","journal-title":"Ann Oncol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clbc.2017.12.001","article-title":"Serum vitamin D levels affect pathologic complete response in patients undergoing neoadjuvant systemic therapy for operable breast cancer","volume":"18","author":"Chiba","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejca.2022.02.003","article-title":"Effects of capecitabine as part of neo-\/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients","volume":"166","author":"van Mackelenbergh","year":"2022","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"R7-20250824","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.breast.2022.01.006","article-title":"Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer","volume":"62 Suppl 1","author":"Harbeck","year":"2022","journal-title":"Breast"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12885-023-10817-2","article-title":"Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jsbmb.2012.09.010","article-title":"Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women","volume":"136","author":"Yao","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/nu14071448","article-title":"Vitamin D and cancer: an historical overview of the epidemiology and mechanisms","volume":"14","author":"Mu\u00f1oz","year":"2022","journal-title":"Nutrients"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"120965","DOI":"10.1016\/j.ijpharm.2021.120965","article-title":"Vitamin D3\/phospholipid complex decorated caseinate nanomicelles for targeted delivery of synergistic combination therapy in breast cancer","volume":"607","author":"Agwa","year":"2021","journal-title":"Int J Pharm"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.3390\/cancers15194833","article-title":"Vitamin D3 inhibits the viability of breast cancer cells in vitro and ehrlich ascites carcinomas in mice by promoting apoptosis and cell cycle arrest and by impeding tumor angiogenesis","volume":"15","author":"Veeresh","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-007-0666-6","article-title":"Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model","volume":"62","author":"Wietrzyk","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"101815","DOI":"10.1016\/j.tice.2022.101815","article-title":"Vitamin D enhances the sensitivity of breast cancer cells to the combination therapy of photodynamic therapy and paclitaxel","volume":"77","author":"Liu","year":"2022","journal-title":"Tissue Cell"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.3390\/ijms222312741","article-title":"Combinations of calcitriol with anticancer treatments for breast cancer: an update","volume":"22","author":"Segovia-Mendoza","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1124\/dmd.118.081612","article-title":"Calcitriol and calcipotriol modulate transport activity of ABC transporters and exhibit selective cytotoxicity in MRP1-overexpressing cells","volume":"46","author":"Tan","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"108865","DOI":"10.1016\/j.cbi.2019.108865","article-title":"Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer","volume":"315","author":"Attia","year":"2020","journal-title":"Chem Biol Interact"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.6004\/jnccn.2023.7062","article-title":"Vitamin D insufficiency as a risk factor for paclitaxel-induced peripheral neuropathy in SWOG S0221","volume":"21","author":"Chen","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J Clin Oncol"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","article-title":"A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival","volume":"12","author":"Ogston","year":"2003","journal-title":"Breast"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","article-title":"Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients","volume":"163","author":"Goorts","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R31-20250824","first-page":"3571","article-title":"Effect of HER2-low-positive status on neoadjuvant chemotherapy and survival outcome of breast cancer: a 10-year dual-center retrospective study","volume":"13","author":"Li","year":"2023","journal-title":"Am J Cancer Res"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1471-2407-11-486","article-title":"Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment","volume":"11","author":"Fasching","year":"2011","journal-title":"BMC Cancer"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaoncol.2023.5033","article-title":"Clinical and biomarker findings of neoadjuvant pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer: NeoPACT phase 2 clinical trial","volume":"10","author":"Sharma","year":"2024","journal-title":"JAMA Oncol"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10549-015-3350-2","article-title":"Race, response to chemotherapy, and outcome within clinical breast cancer subtypes","volume":"150","author":"Tichy","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/nu15061450","article-title":"Prevalence and relevance of vitamin D deficiency in newly diagnosed breast cancer patients: a pilot study","volume":"15","author":"Zemlin","year":"2023","journal-title":"Nutrients"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cam4.235","article-title":"Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007\/150015\/ACRIN6657)","volume":"3","author":"Clark","year":"2014","journal-title":"Cancer Med"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.breast.2015.10.005","article-title":"Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II\/III breast cancer: data from the NEOZOTAC trial (BOOG 10-01)","volume":"25","author":"Charehbili","year":"2016","journal-title":"Breast"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4048\/jbc.2018.21.2.134","article-title":"Association between changes in serum 25-hydroxyvitamin D Levels and survival in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"21","author":"Kim","year":"2018","journal-title":"J Breast Cancer"},{"key":"R40-20250824","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s12885-018-4686-x","article-title":"Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study","volume":"18","author":"Viala","year":"2018","journal-title":"BMC Cancer"},{"key":"R41-20250824","first-page":"388","article-title":"Predictive Importance of Vitamin D on response to neoadjuvant chemotherapy in turkish patients with locally advanced hormone receptor positive breast cancer","volume":"5","author":"Atci","year":"2021","journal-title":"Eur J Med Investig"},{"key":"R42-20250824","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12282-021-01292-3","article-title":"Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy","volume":"29","author":"Tokunaga","year":"2022","journal-title":"Breast Cancer"},{"key":"R43-20250824","first-page":"203","article-title":"Relationship of blood vitamin-D levels on neoadjuvant chemotherapy response of caf (tumor size based on ultrasonographic examination) in post menopause women with locally advance breast cancer in Dr. Soetomo General Hospital Surabaya","volume":"11","author":"Arief","year":"2020","journal-title":"Ind J Publ Health Res Developm"},{"key":"R44-20250824","first-page":"1","article-title":"Effect of neutrophil-to-lymphocyte ratio and vitamin D3 levels on the pathological complete response after neoadjuvant treatment in TNBC and HER2-positive early breast cancer \u2013 results of a prospective study","volume":"1","author":"Meluch","year":"2023","journal-title":"Qeios"},{"key":"R47-20250824","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clnesp.2018.12.085","article-title":"Vitamin D and breast cancer: a systematic review and meta-analysis of observational studies","volume":"30","author":"Hossain","year":"2019","journal-title":"Clin Nutr ESPEN"},{"key":"R48-20250824","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jmwh.12968","article-title":"The significance of vitamin D status in breast cancer: a state of the science review","volume":"64","author":"McNamara","year":"2019","journal-title":"J Midwifery Womens Health"},{"key":"R49-20250824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10654-022-00921-1","article-title":"Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts","volume":"38","author":"Visvanathan","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"R50-20250824","first-page":"1","article-title":"Evaluation of the relationship between serum levels of 25-hydroxyvitamin D and prognostic factors in breast cancer","volume":"95","author":"Heiranizadeh","year":"2022","journal-title":"Pol Przegl Chir"},{"key":"R51-20250824","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaoncol.2016.4188","article-title":"Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study","volume":"3","author":"Yao","year":"2017","journal-title":"JAMA Oncol"},{"key":"R52-20250824","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clbc.2022.01.008","article-title":"The cardioprotective effect of vitamin D in breast cancer patients receiving adjuvant doxorubicin based chemotherapy","volume":"22","author":"El-Bassiouny","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"R53-20250824","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.3390\/ijms22147439","article-title":"Cytoprotective effect of vitamin D on doxorubicin-induced cardiac toxicity in triple negative breast cancer","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R54-20250824","doi-asserted-by":"crossref","first-page":"105947","DOI":"10.1016\/j.jsbmb.2021.105947","article-title":"Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis","volume":"212","author":"Li","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R55-20250824","first-page":"223","article-title":"The correlation between vitamin D levels and demographics in patients with gastrointestinal disorders; a cross-sectional study","volume":"13","author":"Ahmad","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"R56-20250824","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12889-017-4436-z","article-title":"Vitamin D levels and deficiency with different occupations: a systematic review","volume":"17","author":"Sowah","year":"2017","journal-title":"BMC Public Health"},{"key":"R57-20250824","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"key":"R58-20250824","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-018-0754-1","article-title":"Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol","volume":"7","author":"Pathak","year":"2018","journal-title":"Syst Rev"},{"key":"R59-20250824","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsbmb.2015.11.003","article-title":"Vitamin D levels and breast cancer characteristics: findings in patients from Saudi Arabia","volume":"164","author":"Abulkhair","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R60-20250824","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2007.10.013","article-title":"Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer","volume":"17","author":"Dizdar","year":"2008","journal-title":"Breast"},{"key":"R61-20250824","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-007-9647-z","article-title":"Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer","volume":"109","author":"Dizdar","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R62-20250824","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.steroids.2012.06.005","article-title":"The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer","volume":"77","author":"Krishnan","year":"2012","journal-title":"Steroids"},{"key":"R63-20250824","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nutres.2019.03.010","article-title":"Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study","volume":"67","author":"Zhu","year":"2019","journal-title":"Nutr Res"},{"key":"R64-20250824","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4081\/reumatismo.2024.1632","article-title":"Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy","volume":"76","author":"Fassio","year":"2024","journal-title":"Reumatismo"},{"key":"R65-20250824","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.hemonc.2020.08.005","article-title":"Vitamin D baseline levels at diagnosis of breast cancer: a systematic review and meta-analysis","volume":"14","author":"Voutsadakis","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R66-20250824","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.ejca.2014.02.026","article-title":"Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients","volume":"50","author":"Kim","year":"2014","journal-title":"Eur J Cancer"},{"key":"R67-20250824","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-012-2084-7","article-title":"Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy","volume":"134","author":"Jacot","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R68-20250824","doi-asserted-by":"crossref","first-page":"21372","DOI":"10.1038\/s41598-024-72172-x","article-title":"Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial","volume":"14","author":"Tirgar","year":"2024","journal-title":"Sci Rep"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:18:32Z","timestamp":1756063112000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002142","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"2024-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}